ApconiX Welcomes Bethany Russell

Bethany joins ApconiX as a placement student for part of September.  A second-year student, Bethany is studying Biomedical Sciences at Sheffield University.  Her degree is a four-year sandwich course, with a third-year placement in industry.

Bethany was unsure if a career in a laboratory was for her and wanted to be clearer before making her placement year choice.  “It’s difficult to know because the practical courses at University don’t always seem to have a real-world application.  I wanted to experience an actual commercial business first hand to find out what it was truly like.” Bethany speculatively sent her CV to companies in Alderley Park and was delighted when ApconiX said yes.

Bethany thoroughly enjoyed her time with ApconiX working with Dr Michael Morton and Dr Karen Jones as they carry out ion channel screening and assay development.  “I am so pleased I had this opportunity because I now know lab work is definitely for me.”

Mike added “We’ve been very impressed with the motivation of all our placement students this year.  All have sought work with us independently and been keen to obtain real-world experience that complements their work at University.”

By |2018-11-28T15:30:09+00:00October 4th, 2018|Ion Channels, Careers|Comments Off on ApconiX Welcomes Bethany Russell

About the Author:

Dr Michael Morton, PhD, Director and Cofounder, ApconiX, UK, an integrated toxicology and ion channel company that brings together a team of world-renowned nonclinical safety experts with over 400 years of drug discovery and development experience. Mike graduated from the University of Wolverhampton with a degree in Biomedical Sciences and then aspiration to work in hospital pathology. Having finished his Sandwich placement in Clinical Biochemistry at Sandwell Hospital and Mike subsequently gained a MSc in Clinical Biochemistry from the University of Manchester and carried out research into porphyrin metabolism. Moving to the University of Leeds, Mike completed his PhD in Pharmacology at researching adenosine receptor expression in the rat kidney . Mike was introduced to ion channels as a Post-Doc at Leeds and Yale University, patching with the likes of Fred Sigworth and Steve Hebert, then joined the Global Ion Channel Initiative at AstraZeneca. Mike worked at AstraZeneca for eight years before founding ApconiX with Professor Ruth Roberts and Dr Richard Knight. Mike has a serious passion for ion channels. And he’s very good at them . He is a serious scientist (with a serious sense of humour) who wants to make sure that every customer understands the consequences of the results he obtains and works with his colleagues to ensure a better decision is made on drug safety.